Predictive modeling of aspirin‐triggered resolvin D1 pharmacokinetics for the study of Sjögren's syndrome

OBJECTIVES: Sjögren's syndrome (SS) is an autoimmune disease that causes chronic inflammation of the salivary glands leading to secretory dysfunction. Previous studies demonstrated that aspirin‐triggered resolvin D1 (AT‐RvD1) reduces inflammation and restores tissue integrity in salivary glands...

Descripción completa

Detalles Bibliográficos
Autores principales: Yellepeddi, Venkata Kashyap, Baker, Olga J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133737/
https://www.ncbi.nlm.nih.gov/pubmed/32250566
http://dx.doi.org/10.1002/cre2.260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133737/
https://www.ncbi.nlm.nih.gov/pubmed/32250566
http://dx.doi.org/10.1002/cre2.260

Ejemplares similares